Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 05ZAGREB1199, PATENT LINKAGE IN CROATIA -- TOUGH BUT

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05ZAGREB1199.
Reference ID Created Released Classification Origin
05ZAGREB1199 2005-07-19 15:25 2011-08-25 00:00 UNCLASSIFIED Embassy Zagreb
This record is a partial extract of the original cable. The full text of the original cable is not available.

191525Z Jul 05
UNCLAS  ZAGREB 001199 
 
SIPDIS 
 
 
STATE FOR EB/IPC JOELLEN URBAN 
STATE PASS USTR 
USDOC PASS TO USPTO 
 
E.O. 12958: N/A 
TAGS: ETRD ECON KIPR HR
SUBJECT: PATENT LINKAGE IN CROATIA -- TOUGH BUT 
POSSIBLE 
 
REF: A) URBAN/DETWILER EMAIL 
 
B) ZAGREB 666 
 
SUMMARY AND ACTION REQUEST 
-------------------------- 
 
1.  WE APPROACHED THE HEADS OF THE CROATIAN DRUG 
AGENCY AND THE STATE INSTITUTE FOR INTELLECTUAL 
PROPERTY TO HIGHLIGHT THE ROLE THAT LACK OF PATENT 
LINKAGE IN THE DRUG REGISTRATION PROCESS PLAYED IN 
CROATIA'S REMAINING ON THE SPECIAL 301 WATCH LIST. 
WE SHARED THE DOCUMENT DRAFTED BY USPTO (REF A) THAT 
DESCRIBES THE U.S. PATENT LINKAGE SYSTEM.  IN THE 
CASE OF THE DRUG AGENCY, WE MET CONSIDERABLE 
RESISTANCE TO INTRODUCING ANY SORT OF PATENT 
LINKAGE.  THE DIRECTOR MADE CLEAR THAT HE DID NOT 
WANT TO "GO INTO THE PATENT BUSINESS," AND THAT HE 
THOUGHT THAT THE ISSUE WAS ACADEMIC NOW THAT DATA 
EXCLUSIVITY HAS BEEN INTRODUCED 
 
2.  THERE WAS A MORE OPEN ATTITUDE AT THE IP 
INSTITUTE, BUT MANY QUESTIONS AS WELL.  WE ARE 
PREPARED TO PUSH AHEAD ON THIS ISSUE, BUT WILL NEED 
TO HAVE FURTHER EXPERT INPUT FROM WASHINGTON 
AGENCIES.  WE PROPOSE SETTING UP A DVC WITH THE KEY 
PLAYERS IN CROATIA AND EXPERTS FROM USPTO AND FDA. 
END SUMMARY AND ACTION REQUEST. 
 
DRUG AGENCY -- WHAT LEGAL BASIS? 
-------------------------------- 
 
3.  WE MET WITH DR. SINISA TOMIC, HEAD OF THE 
CROATIAN DRUG AGENCY.  THIS WAS THE SECOND TIME WE 
HAD RAISED THE ISSUE WITH HIM (SEE REF B).  AGAIN HE 
RAISED THE LACK OF A LEGAL REQUIREMENT TO REQUIRE 
PROOF OF LACK OF PATENT INFRINGEMENT.  AFTER 
EXAMINING THE PTO DOCUMENT, TOMIC SAID HE DID NOT 
BELIEVE THE DRUG AGENCY HAD THE PERSONNEL, EXPERTISE 
OR MANDATE TO PERFORM THE "PATENT GUARDIAN" ROLE THE 
FDA APPARENTLY PLAYS.  FINALLY, HE SAID THAT NOW 
THAT THERE IS A REQUIREMENT FOR THE AGENCY TO 
PROTECT DATA EXCLUSIVITY (BASICALLY, NO GENERIC FIRM 
CAN REGISTER A DRUG, PATENTED OR NOT, IF THE 
ORIGINAL HAS NOT BEEN ON THE CROATIAN MARKET FOR 
MORE THAN SIX YEARS), THE ISSUE WAS MOOT.  WHEN WE 
ASKED ABOUT PUBLISHING MARKETING REGISTRATIONS 
REQUESTS ON THE INTERNET UPON FILING, AS IS 
APPARENTLY DONE IN ROMANIA, DR. TOMIC SAID THIS 
WOULD BE A VIOLATION OF BUSINESS CONFIDENTIAL 
INFORMATION. 
 
STATE INSTITUTE FOR INTELLECTUAL PROPERTY -- CAN DO 
IN THEORY, BUT... 
--------------------------------------------- ------ 
 
4.  ZELJKO TOPIC, DIRECTOR OF THE STATE INSTITUTE 
FOR INTELLECTUAL PROPERTY, WAS MORE OPEN.  HE ASKED 
WHAT LAW GAVE THE FDA THE MANDATE TO MAINTAIN AN 
"ORANGE BOOK" AS DESCRIBED IN THE PTO PAPER.  THE 
HEAD OF THE PATENT DEPARTMENT NOTED THAT FIVE OR SIX 
YEARS AGO, THERE HAD BEEN A PROPOSAL TO REQUIRE THAT 
THE DRUG AGENCY CHECK FOR PATENTS BEFORE ISSUING 
MARKETING AUTHORIZATION, BUT THE PROPOSAL HAD NEVER 
MADE IT INTO THE LAW ON DRUG REGISTRATIONS.  TOPIC 
CONFIRMED THAT SHOULD THE DRUG AGENCY ASK FOR A 
RULING ON THE EXISTENCE OF A PATENT, THE INSTITUTE 
COULD GIVE IT ("THAT'S OUR JOB.")  HOWEVER, HE NOTED 
THAT THE AGENCY WOULD VERY LIKELY NOT BE ABLE TO 
GIVE A CLEAR CUT ANSWER ABOUT THE DATE OF EXPIRING 
OF A PATENT, BECAUSE FIRMS CAN FILE FOR A 
SUPPLEMENTARY PATENT CERTIFICATE.  ALSO, THE ISSUE 
OF PROCESS PATENTS WOULD COMPLICATE MATTERS (MOST OF 
THE PATENT DISPUTES WE KNOW OF CONCERN "PROCESS 
PATENTS," IN WHICH ONLY THE PROCESS, NOT THE 
PRODUCT, IS PROTECTED, THUS THE GENERIC FIRMS 
UNIFORMLY ARGUE THEY DEVISED A NEW PROCESS TO GET TO 
THE IDENTICAL DRUG). 
 
5.  ONE OF THE ATTORNEYS PRESENT AT THE MEETING ALSO 
SAID THAT THE DRUG AGENCY WOULD HAVE DIFFICULTLY 
TURNING DOWN MARKETING AUTHORIZATIONS BASED SOLELY 
 
ON THE EXISTENCE OF A PATENT HELD BY ANOTHER PARTY. 
"THE INFRINGEMENT IS WHEN THE COPY IS SOLD -- THERE 
IS NO LEGAL REASON SOMEONE CANNOT FILE FOR MARKETING 
AUTHORIZATION EARLY, IN ORDER TO PUT THE DRUG ON THE 
MARKET AS SOON AS THE PATENT EXPIRES."  THERE WERE 
SEVERAL QUESTIONS ABOUT HOW THE PROCESS WORKS IN THE 
U.S. -- WHAT HAPPENS IF THE FILER IGNORES THE ORANGE 
BOOK?  DOES THE FDA REFUSE TO ISSUE THE 
REGISTRATION?  UPON WHAT LEGAL BASIS DOES THE FDA 
REFUSE REGISTRATION? 
 
COMMENT AND ACTION REQUEST 
-------------------------- 
 
6.  WE BELIEVE THAT THE GOVERNMENT OF CROATIA MAY BE 
OPEN TO INTRODUCING PATENT LINKAGE, IF THE SYSTEM IS 
AS SIMPLE AND EASY TO IMPLEMENT AS POSSIBLE.  THE 
DRUG AGENCY WILL NOT WANT TO DO MORE THAT ASK FOR AN 
"OK" FROM THE IP INSTITUTE.  THE INSTITUTE WILL WANT 
TO RESTRAIN ITSELF PURELY TO PATENT ISSUES, NOT 
COMMERCIAL ISSUES.  WHILE WE FREQUENTLY REMIND THE 
GOC THAT JUST BECAUSE THE EU DOES (OR DOES NOT) DO 
SOMETHING DOESN'T MEAN THAT SOMETHING IS GOOD ENOUGH 
FOR US, IT WOULD BE HELPFUL IF WE COULD POINT TO A 
PATENT LINKAGE OPERATION IN THE EU.  ALSO, THE PTO 
DOCUMENT RAISES A FAIR NUMBER OF QUESTIONS, MANY OF 
THEM QUITE TECHNICAL.  THEREFORE, WE REQUEST THAT A 
DIGITAL VIDEO CONFERENCE BE SET UP, PROBABLY IN 
SEPTEMBER, WITH EXPERTS FROM USPTO AND THE FDA AND 
COUNTERPARTS FROM THE CROATIAN IP INSTITUTE AND DRUG 
AGENCY. 
 
FRANK